Y-Biologics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 8, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	377,934	347,578	113,678	230,299	-	-
Market Cap Growth	263.67%	205.76%	-50.64%	-	-	-
Enterprise Value	348,418	324,452	102,035	230,749	-	-
Last Close Price	24900.00	22900.00	7690.00	15600.00	-	-
PS Ratio	129.74	119.32	19.73	66.19	-	-
PB Ratio	14.21	13.07	5.79	8.86	-	-
P/TBV Ratio	14.50	13.33	6.27	9.94	-	-
EV/Sales Ratio	119.61	111.38	17.71	66.33	-	-
Debt / Equity Ratio	0.56	0.56	0.04	0.11	0.25	0.21
Net Debt / Equity Ratio	-1.11	-1.11	-0.58	-0.69	-0.40	-0.39
Net Debt / EBITDA Ratio	4.02	4.02	1.78	2.31	0.51	0.73
Net Debt / FCF Ratio	4.30	4.30	1.63	2.31	0.72	0.66
Asset Turnover	0.08	0.08	0.22	0.12	0.12	0.11
Quick Ratio	35.93	35.93	10.58	7.39	1.60	2.91
Current Ratio	36.16	36.16	10.73	7.48	1.70	3.20
Return on Equity (ROE)	-181.79%	-181.79%	-28.23%	-90.84%	-77.73%	-54.50%
Return on Assets (ROA)	-14.95%	-14.95%	-20.30%	-21.27%	-34.84%	-24.67%
Return on Capital Employed (ROCE)	-17.00%	-17.00%	-41.10%	-37.00%	-90.60%	-54.20%
Earnings Yield	-11.12%	-12.09%	-5.67%	-9.06%	-	-
FCF Yield	-1.82%	-1.98%	-6.16%	-3.39%	-	-
Buyback Yield / Dilution	-0.79%	-0.79%	-18.02%	-1.85%	-1.01%	-21.93%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.